Lv12
20 积分 2023-12-13 加入
Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors
4小时前
待确认
P2.14A.01 Clinicopathological Characteristics and Treatment Outcomes of Patients with Advanced SMARCA4-Deficient Non-Small Cell Lung Cancer
4小时前
待确认
Abstract 1138: Novel SMARCA2 degrading bifunctional molecules as therapeutics in SMARCA4 mutant lung cancer
4小时前
求助中
Abstract 3304: Modulation of enhancer accessibility by SMARCA2 PROTACs synergize with TEAD inhibitors to suppress growth of SMARCA4 mutant lung cancers
4小时前
求助中
Abstract B113: Discovery of PRT3789, a first-in-class potent and selective SMARCA2 degrader in clinical trials for the treatment of patients with SMARCA4 mutated cancers
4小时前
求助中
Abstract 6270: Combination therapy with selective SMARCA2 (BRM) degraders for treatment of SMARCA4 (BRG1)-deficient cancers
4小时前
求助中
OA18.06 Characteristics and Outcomes of Patients with SMARCA4-Deficient Undifferentiated Thoracic Tumors
5小时前
已完结
Abstracts from USCAP 2021: Cytopathology (158-237)
6小时前
已完结
Clinicopathologic characteristics and immunotherapy outcomes in SMARCA4-mutant (mut) non-small cell lung cancer (NSCLC)
11小时前
已完结
Clinicopathologic characteristics and molecular features of BRG1-deficient non-small cell lung cancer (NSCLC)
11小时前
已完结
皖公网安备34019202002308
